Director's Dealing • Jun 13, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
| 1 | Details of the Primary Insider/Close Associate | |||
|---|---|---|---|---|
| a) | Name | Jonathan Allis | ||
| 2 | ||||
| a) | Position/status | Board member | ||
| b) | Initial notification/ Amendment |
Initial notification | ||
| 3 | Details of issuer | |||
| a) | Name | EXACT Therapeutics AS | ||
| b) | LEI | 2138006ZE5JAL39AGD55 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each | |||
| type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial | Nature of the instrument: Share options related to shares in EXACT | ||
| instrument, type of |
Therapeutics AS with ISIN NO 0010852213 | |||
| instrument | ||||
| Identification code | ||||
| b) | Nature of the transaction | Grant of share option | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 0 | 569,370 | |||
| d) | Aggregated information | Price: NOK 0. A strike price must be paid upon exercise of the options. | ||
| - Aggregated volume | Volume: 569,370 | |||
| - Price | ||||
| e) | Date of the transaction | 2025-06-13 | ||
| f) | Place of the transaction | Outside of trading venue |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.